Showing results (451-460 of 6,691) with videos related to
Sort By:
Pageof 670
Journal of Cardiovascular Electrophysiology|November 1, 1996
Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfallsD S Rosenbaum, P Albrecht, R J CohenJournal of Cardiovascular Electrophysiology|July 1, 1996
Atomic (scanning) force microscopy in cardiovascular researchM F Arnsdorf, S XuJournal of Cardiovascular Electrophysiology|March 1, 1996
Effects of high and low shock energies on sinus electrograms recorded via integrated and true bipolar nonthoracotomy lead systemsC D Gottlieb, D S Schwartzman, D J Callans, et al.Journal of Cardiovascular Electrophysiology|March 1, 1996
Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugsG L Dolack, J E Poole, P J Kudenchuk, et al.Journal of Cardiovascular Electrophysiology|March 1, 1996
Cardiac output is not affected during intraoperative testing of the automatic implantable cardioverter defibrillatorJ Meyer, T Möllhoff, T Seifert, et al.Journal of Cardiovascular Electrophysiology|February 1, 1996
Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulationP T Sager, M BehboodikhahJournal of Cardiovascular Electrophysiology|February 1, 1996
Atrial natriuretic peptide and cardiac electrophysiology: autonomic and direct effectsH F Clemo, C M Baumgarten, K A Ellenbogen, et al.Journal of Cardiovascular Electrophysiology|May 1, 1996
Defibrillation shocks over epicardial patches produce sympathetic neural dysfunction in manL B Rigden, R D Mitrani, H N Wellman, et al.Journal of Cardiovascular Electrophysiology|October 1, 1995
Parenteral antiarrhythmics for life-threatening ventricular arrhythmiasR A Filart, S J Rials, R A Marinchak, et al.Journal of Cardiovascular Electrophysiology|October 1, 1995
Parenteral antiarrhythmic drug therapy in ventricular tachycardia/ventricular fibrillation: evolving role of class III agents--focus on amiodaroneM M ScheinmanPageof 670